The High-Stakes Gamble: Summit's Vision vs. Akeso's Strategic Play with Ivonesimab
Summit Therapeutics Soars: Cancer Drug Ivonesimab Delivers Breakthrough Survival Gains, Igniting Retail Investor Frenzy